Alzheimer's
The model can also make zero-shot predictions.
The company plans to add additional features as well as to continue its expansion into Asian markets.
The Montreal-based company uses spectral retinal imaging technology and AI to deliver a cheaper alternative to early Alzheimer's disease detection.